Author Archives: ev1
"Owsten Collection" Auction Report












The following report (and these photos!) just in from my friend Lisa O'Sullivan, who is based in Australia and who kindly offered to spy on the auctioning off of the Owsten collection, an amazing collection of naturalia, decorative arts and curiosities amassed by millionaire Warren Anderson and his now estranged wife. The auction took place last Friday and Saturday in Sydney, Australia and here is what Lisa had to say about the spectacle:
In the end, there were no last-minute invasions from the previous owner of the collection, who had threatened to disrupt the sale. He argued that the auction house Bonhams had seriously undervalued his collection. Looking at some of the final auction prices, he may have had a point. Many pieces went significantly over reserve, especially the taxidermy which had been, often ridiculously*, under valued (*she says, with zero authority, but all the bitterness of a taxidermy enthusiast of limited means - the birds I liked having a reserve of A$400 - $600 but selling at A$6,600 (US$5,768), over 10 times that).
For the pre-auction viewing, the collection was displayed in the overseas ferry terminal at Circular Quay, opposite the Sydney Opera house. This was a good thing, because every so often, my retinas needed a rest, and I could step out for some air and gaze at the harbour for a while (calm, washed out blues, very soothing to the eyes). When we say ferry terminal, this is a cavernous space, designed to deal with the massive cruise ships that descend on Sydney. Despite the scale, it felt absolutely jam-packed with over 1,300 objects, many of them made up into room dioramas, like a version of IKEA, designed for, as my friend Felix said, someone looking to furnish an entire Carpathian Castle all at once.
The room was edged with Japanese suits of armour, standing to attention between cabinets and chests of drawers, all with their obligatory taxidermy on top. Looking around, every available surface seemed to be covered with cases. The taxidermy was very varied, some amazing pieces, next to some very dodgy dioramas, and examples in a bad state of repair. Among the saddest were the little birds with stuffing coming out of their eye sockets where fake eyeballs had fallen out.
Add to this, job lots of boomerangs (I heard one staff member complaining to another that his life had shrunk to a point where it was purely dedicated to counting boomerangs in and out of boxes), art nouveau sculptures jostling with ethnographic masks, castle-scaled wooden furniture and a seemingly endless array of trophy heads.
Rumour had it the interest in the rhinoceros horns and heads was fuelled by their medicinal potential (rhino horn is a traditional Chinese remedy against fever). As trade in these horns is now banned, antique examples are the only legal means of procuring them. In any case, a single horn sold for A$90,000 (US$78,655).
For me the most bizarre heads were the wombat trophies. I always understood the ‘heads on a wall’ to gesture towards the prowess of the hunter (all aspects of unfair advantage aside). Despite my best efforts, it’s hard to picture a ‘man v beast’ hunting scenario that involves wombats (also known as the animals most likely to cause a danger to humans as trip hazards in the dark) and a fight to the death any hunter could be proud of...
And the monkey and cat barbershop? A$24,000 (US$20,975) - A$9,000 over reserve. Time to set up a Morbid Anatomy acquisition fund so we can be ready next time?
Addendum: At the end of the day, the entire Owsten Collection sold for A$12 million - double the auction houses estimate, but still under the A$20 million the owner claimed.
Thanks so much, Lisa, for this awesome report and images! So wish I could have been there myself! It looks (and sounds) even more epic than I had expected! To find out more about the collection and to see more images, you can visit this recent pre-auction post.
All images are from Lisa's visit to the auction pre-sale. You can see the entire set of images (well worth your while!) by clicking here.
Stolen Caravaggio Is Recovered
A Caravaggio painting considered to be the most valuable work of art in Ukraine was recovered in Germany, two years after it was stolen from a museum in Odessa, Reuters reported. The painting, below, called “The Taking of Christ” or “The Kiss of Judas,” was made by Caravaggio in the early 17th century, and depicts Jesus and his apostles John and Judas as they are being separated by soldiers. It had belonged to a Russian ambassador to France and a Russian prince before it was turned over to the Odessa museum, where it was stolen in 2008. On Tuesday Anatoly Mogylyov, the interior minister of Ukraine, said in a briefing that the Ukrainian and German police had recovered the painting and detained members of a gang that focuses on high-value thefts who had tried to sell the work in Berlin.
Various Works by Eran Webber
Eran Webber is a figurative artist born in Israel in 1980, and currently living in Florence, Italy. At the moment, he is studying and teaching at the Florence Academy of Art Sculpting program.
To learn more about Eran Webber, please visit his upcoming site at http://www.eranwebber.com, or through his facebook page.
S.C. Medical Board considers anatomic pathology services arrangements
An issue was recently brought to the attention of the SC Board of Medical Examiners on behalf of the South Carolina Society of Pathologists dealing with certain anatomic pathology business practices that have ethical and legal considerations that practicing pathologists should be aware of. The matter was presented to the Board by Jane Pine Wood, Esq. and Steven M. Harris, Esq. and recently responded to by the Board. Documents of the request and response are available on the SC Board of Medical Examiners website (links below correct - wrong on source page).
The documents are worth reading for background and the types of business models that may be occurring and what it means for our specialty. Welcome your comments.
"At its May 2010 meeting, the SC Board of Medical Examiners considered the legal and ethical issues related to certain anatomic pathology services arrangements. The board concluded that the arrangements in question may constitute misconduct under the medical practice act. While it has not received a complaint and has not investigated any specific arrangement, based on the facts outlined in the presentation made at the May meeting these relationships raise serious legal and ethical concerns. Accordingly, the board cannot advise that they are permissible under the medical practice act at this time.
May 13, 2010 letter to the SC Board of Medical Examiners requesting advice from the Board about certain anatomic pathology services click here.
June 9, 2010 letter of response from the Board click here."
http://www.llr.state.sc.us/pol/medical/PDF/pathology%20final.pdf
http://www.llr.state.sc.us/pol/medical/PDF/PathologyWoodRequest.pdf
http://www.llr.state.sc.us/pol/medical/PDF/PathologyWoodResponse.pdf
Case of the Week 55
Here’s a challenge for all of you: Nasal polyp removed from a 50 year old Indian man with complaints of chronic nasal obstruction. Histologic exam reveals the following:
This Tuesday at Observatory! Torino:Margolis Performance

This Tuesday! Morbid Anatomy presents at Observatory! Hope to see you there!
Torino:Margolis Performance
A performative exploration of electricity, biomedicine, and spectacle
Date: June 29, 2010
Time: 8:00 P.M.
Admission: $5
Please note: This lecture is paired with an event which took place on Tuesday, June 15; More here.Tonight, join Observatory as it hosts Torino:Margolis in a three-part performance investigating the rich history of biomedicine, electricity, and spectacle. First, the audience will have the opportunity to control the movement of the performer using neuromuscular stimulation, which sends outside electricity into the performer’s muscle, forcing their muscle to contract and the performer to move involuntarily.
In the second part of the performance, they will use electromyography (EMG) in a sound-based performance. EMG is a way of sensing the electricity produced naturally during muscle contraction when an individual moves voluntarily. However, when the performer is physically manipulated by another person there is no action potential generated, no signal sensed by the EMG, and no change in the sound is produced. In this way you can hear someone’s free will.
In the third portion they will add a vocal component to the EMG “rig” by manipulating sound coming from the vocal cords using neuromuscular stimulation.
Torino:Margolis will then explain the workings of the biomedical tools used in the performance and the audience will have the opportunity to ask questions.
Torino:Margolis is a performance art team that smashes through physical and psychological barriers separating one body from another using invasive electronics and biomedical tools. They explore the idea that the self is transient, elusive and modular by playing with the notion of control and free will. Their extraction of physiological processes concretizes these concepts and presents them as questions to the viewer — not to illustrate the mechanism, but to explore the experience. The team has performed nationally and internationally at New York venues such as Issue Project Room, POSTMASTERS Gallery and Exit Art, the HIVE Gallery in California, and the Bergen Kunsthall Museum in Norway. They have lectured for institutions such as SUNY Stony Brook and the School of Visual Arts. For more information please see http://www.torinomargolis.com.
You can find out more about this here. You can get directions to Observatory--which is next door to the Morbid Anatomy Library (more on that here)--by clicking here. You can find out more about Observatory here, join our mailing list by clicking here, and join us on Facebook by clicking here.
www.GoPathDx.com
http://Www.GoPathDx.com is a new premier interactive pathology web portal founded by a group of pathologists in Indianapolis, Indiana, USA. The site serves as a pathology resource center where pathologists around the world can access information related to pathology learning, training, ongoing practice, continuing education and job opportunities. Additionally, the site also provides a place for social networking amongst professional colleagues. Featured function tabs include top news, pathology journals, lectures, a case of the week, telepathology, research updates, jobs and conferences. The site is very user-friendly and interactive, where pathologists can write their own diagnosis for a case of the week, post cases themselves to initiate a discussion, or make a comment about certain products they use. It is a great place to find information and place your advertisements as well.
Simply register with your e-mail, tell us where you are from (optional) and create a user name and password, then you can enjoy all the information of the site. The only reason we need your e-mail address is to be able to update you with upcoming events that may interest you, such as new lectures, new CME courses, new job opportunities and even new IHC Abs info that may be useful for your practice. We will not share your e-mail address with any third party.
Should you have any questions, comments or even complaints, please feel free to let us know. GoPathDx.com is here for you and your local pathology community.
Come and Join GoPath Global Community!
BP is burning rare sea turtles alive, blocking efforts to save them
By now, almost everyone is aware of the out-of-control oil spill down in the Gulf of Mexico that seems to be getting exponentially worse with each passing day. But what people may not know is that BP's efforts to control the oil by burning it are actually burning alive a certain rare and endangered species of sea turtle.
For several weeks now, rescue crews have been feverishly trying to save Kemp's Ridleys sea turtles, as well as four other endangered varieties, from being caught in the oil corral areas that are being intentionally burned by BP, but according to Mike Ellis, one of the boat captains involved in the project, BP has now blocked all such rescue efforts from taking place.
"They ran us out of there and then they shut us down, they would not let us get back in there," he explained in an interview with Catherine Craig, a conservation biologist.
According to Dr. Brian Stacy, a veterinarian with the National Oceanic and Atmospheric Administration, there are five different endangered sea turtles living in the Gulf that are all at risk, but the type being found "dead or covered in oil" the most is the Kemp's Ridleys variety, which is the rarest species of them all. Read more...
Kama Raja Old Formula for Penis Enhancement!
Pathology Informatics 2010 – Sept 19-22, Boston, MA – Mark your Calendars
It goes without saying that this is THE pathology informatics meeting of the year and brings together two historically strong meetings - APIII and Lab InfoTech Summit (AIMCL prior to that).
Outstanding faculty at a great venue. Travel awards and CME availalble.
Whether you are a rookie or a seasoned veteran between the 3 tracks (see below) listed below from the conference website, this meeting will offer something to everyone.
Another added deliverable of combining forces to have this meeting is the breadth and depth of exhibitors who will attend outnumbering either meeting on its own.
Click here to download conference brochure (PDF)
Pathology Informatics 2010 (PI-2010) is the product of more than 40 cumulative years of experience in providing continuing medical education in the area of pathology informatics. Its predecessor conferences were: (1) AIMCL, held in Ann Arbor from 1983 to 2003; (2) APIII held in Pittsburgh from 1996 to 2009; and (3) Lab InfoTech Summit from 2004 to 2009. A decision was made last year to merge these events into a single mega-event, bringing together their directors and staffs under the sponsorship of the Department of Biomedical Informatics, University of Pittsburgh, and the Association for Pathology Informatics, API.
Pathology Informatics, a subdiscipline of pathology and clinical laboratory medicine, is growing rapidly. In recognition of this fact, we offer registrants to PI-2010 three workshops on the first day of and three tracks on the subsequent two and one-half days. The three tracks are the following: (1) Applied Informatics; (2) Advanced and Experimental Informatics; and (3) Pathology Imaging Informatics. These three tracks are punctuated by plenary lectures to the whole group by noted pathologists and scientists. The first of these tracks closely approximates the previous Lab InfoTech Summit held in Las Vegas and the latter two track closely to previous APIII offerings.
We view the role of the exhibitors at PI-2010 as essential to the learning mission because they serve as partners in the deployment of new information management systems. Because the training of pathology residents and fellows in pathology informatics is essential to our mission, we have also taken special efforts to award travel grants to them in programs across the country and encourage pathology program directors to view the PI-2010 experience as an “away rotation” for such trainees. Special discounts on the registration fees are offered to them as well as to API and HIMA members.
Who Should Attend?
Pathology Informatics 2010 is an annual educational conference designed for world-wide collaboration, technology and learning together to come together in one meeting place.
PI2010 offers direct interaction with physicians, researchers, residents and graduate students, Industry-related developers, engineers, imaging informatics professionals, vendor representatives and many others interested in how informatics and imaging are transforming pathology, oncology and radiology. Prior knowledge of informatics is not required and courses are offered for individuals new to this field.
Conference Highlights
Three pre-conference workshops and three tracks to choose from over the course of the four conference days.
An eminent faculty consisting of most of the national experts in the field of pathology informatics in the country and from abroad.
Dawn-to-dusk programming over the course of four days including a gala welcoming reception on the first night of the conference and formal lecture-demonstrations by a selection of exhibitors.
Elegant conference space and room accommodations at the Westin Copley Place, one of the finest hotels in Boston.
Overall Conference Objectives
Present practical and emerging solutions for automated information and image management in pathology and the clinical laboratories.
Describe how workflow in the clinical laboratories and pathology can be supported and enhanced by new software and hardware solutions.
Understand the various software and hardware products available in the clinical laboratory and pathology market by interacting with a large number of exhibitors.
Present new research in pathology informatics on the basis of submitted competitive scientific abstracts.
Provide a forum for basic pathology informatics instruction for house officers and fellows in pathology training programs.
Is the iPad Radiology’s Dream Device For Mobile Healthcare?
One could substitute "pathology" for "radiology" given similar workflow and resolution issues and make the same arguments...
Is the iPad radiology's dream device for mobile healthcare?
By Erik L. Ridley
AuntMinnie staff writer
June 24, 2010
It's the mobile device that's taking the consumer electronics world by storm. But does the iPad have a role in medical imaging? Early adopters say yes -- they believe the iPad could unlock the potential of mobile computing in radiology.
The iPad has only been on the market for three months, but it has already generated significant interest and enthusiasm among radiologists and referring physicians. Efforts to define the role of the iPad in radiology are still in their early stages, but a number of researchers and vendors active in developing software applications for the iPad believe it could fulfill a role in bringing access to images and advanced visualization technology to the point of care.
Widespread utilization, however, will require addressing a number of challenges, not the least of which is security.
Packing a punch
The iPad owes its potential in radiology to its mix of size, portability, battery life, and relatively high spatial and contrast resolution, said Mark McEntee, PhD, a lecturer of diagnostic imaging at the University College Dublin School of Medicine and Medical Science in Dublin, Ireland.
The iPad's vital statistics also compare favorably to the previous mobile platform of choice, the iPhone. The iPad's 9.7-inch display provides 1024 x 768-pixel resolution at 132 pixels per inch (PPI), while the iPhone 4 has a 3.5-inch (diagonal) display with a resolution of 640 x 960, although the iPhone sports 326 PPI. The iPad weighs just 1.5 lb, much less than most conventional laptops.
The larger display allows images to be displayed at or closer to their native resolution than they would on smaller portable devices, McEntee said. The battery life of the iPad is also an advantage over the iPhone; McEntee reported using the iPad for two busy days of eight-hour use without having to recharge.
"The sleep mode is fast and responsive and uses tiny amounts of energy," McEntee said. "This is a huge advantage [over] the iPhone, whose battery finds it hard to keep up with the demands of the power-hungry display."
Clinical benefit
The iPad will likely have significantly more value within a clinical environment than the iPhone, said Mark Cain, chief technology officer of advanced visualization firm MIMvista of Cleveland.
"When you consider sitting with a patient and explaining the results of a scan, there is nothing more personal than being side-by-side, images in hand," he said. "The iPhone is the more portable choice and will be better suited for those who need access at any time, not just in the hospital."
The additional resolution on the iPad is like gold for a radiologist, Cain said.
"The amount of panning required to see a large image is significantly reduced, and that saves time," he said.
The most obvious uses for the iPad in radiology include reviewing images, reading reports, and accessing medical records, said Janice Honeyman-Buck, PhD, editor in chief of the Society for Imaging Informatics in Medicine's Journal of Digital Imaging.
In addition to the larger, high-quality screen, physicians will appreciate the speed of the iPad, Honeyman-Buck said in an e-mail to AuntMinnie.com.
"It turns on quickly, seems to open and display websites and documents faster than most laptops, and it is easy and intuitive to use," she said.
The ability to provide mobile and secure access to scheduling, patient information, historical images, and other key information without being tied down to a PC offers an opportunity for efficiency gains, said Paul Merrild, senior vice president of marketing and business development at advanced visualization and healthcare IT developer Merge Healthcare of Milwaukee.
"iPads can theoretically contain the entire electronic record of the patient's imaging experience, and can be handed along the workflow as needed," Merrild said. "At the end, the iPad has potential to provide a nice teaching and communication tool between the radiologist, referring physician, and the patient."
Radiologists could review a worklist, see overall activity within the imaging practice, view preliminary images from a technologist, or sign reports using the iPad, Merrild said. The iPad could also provide access to the Web for reference information and offer instant viewing of an electronic health record (EHR).
"This device can facilitate movement of studies as needed, communication among anyone involved in a study, and sharing of images with patients," Merrild said. "In a hospital setting, images could be given to all clinical team members at the patient's bedside. The iPad could, in essence, become a portable film jacket, but one with so much more information included."
MIMvista's Cain said that every imaging application would be compelling on the iPad.
"When you consider that the iPhone screen already makes some PACS viewers from the past look dull, the iPad is just brilliant," Cain said. "Furthermore, we think every current HIS/EMR/PACS system could have an iPad interface. It seems like it would be much more economical for hospitals to have personnel carrying iPads than hundreds of PCs taking up space in every room."
The iPad also shows promise for viewing images from PACS and viewing live procedure video, according to Tony Molinari, vice president of sales and marketing at PACS developer Foresight Imaging of Lowell, MA.
3D content
Thanks to its larger size and improved resolution, the iPad offers more potential than the iPhone for using thin-client advanced visualization software, said Vikram Simha, chief technology officer at advanced visualization firm Vital Images of Minnetonka, MN. The company has seen interest from a number of its customers in using the iPad with its 3D software.
"We see a good opportunity for bringing image/result review to the bedside with an iPad to improve communication between radiology and the referring physician," Simha told AuntMinnie.com. "It has the right form factor and resolution to bring advanced visualization to the referring physician, closer to patient care."
The iPad also offers the potential for delivering interactive, rich 3D content directly into the hands of a surgeon or other referring physicians, according to Robert Taylor, PhD, president and CEO of advanced visualization vendor TeraRecon of San Mateo, CA. The iPad's design as primarily a content viewer rather than a content production device even fits radiology's traditional workflow model.
"This 'consumption' of content created by radiology, without much ability to 'create' content directly, seems to be a great fit for the respective roles and goals of radiology and its physician customers," Taylor said.
Primary diagnosis?
But don't expect radiologists to ditch their PACS workstations and start interpreting images on iPads any time soon. The iPad would not be suitable for primary diagnosis due to its contrast ratio (maximum luminance/minimum luminance) and calibration issues, McEntee said.
For example, the iPad has a maximum luminance of 270 cd/m2, which, while higher than the average of 150-200 cd/m2 seen in off-the-shelf displays, is much lower than your average primary interpretation display, which has an average maximum luminance of 500-600 cd/m2. The iPad's minimum luminance is 0.3 cd/m2, which yields a still impressive contrast ratio of 900:1 for a portable device; the iPhone and Dell Axim v51 both have a contrast ratio of 100:1, McEntee said.
Display calibration is also an issue, McEntee said. "The iPad cannot currently be calibrated as software [and] cannot be installed in the normal way; presumably, we would 'need an app for that,' " he told AuntMinnie.com.
In addition to commercial offerings, the popular open-source OsiriX DICOM image viewer will undoubtedly make its way to the iPad, although an iPad-specific version is not yet available.
The current OsiriX version for the iPhone can be viewed on the iPad's full screen using the iPad's 2x button. However, this magnification can accentuate the resolution differences between the iPad and iPhone, leading to grainy text. "Presumably, later releases will solve this," McEntee said.
An OsiriX version for the iPad is listed as "soon available," according to a January 29, 2010, post on the OsiriX website.
Ed Heere, president and CEO of CoActiv Medical Business Solutions of Ridgefield, CT, said the company's OsiriX-integrated iPhone application can work well on the iPad as a temporary solution, providing four times the viewing size as measured in square inches as the iPhone when using the viewer's 2x button.
"The high-resolution iPad screen provides a bright, crisp image even at the enlarged size," Heere said. "Future iPad-specific apps will allow simultaneous viewing of current and prior studies as well as multiple series/image windows and much greater add-in functionality."
Other educational apps will also likely find use on the iPad, McEntee said.
Limitations
For all of its advantages, the iPad does come with some limitations to its use in radiology applications. One of the main concerns with clinical use of the iPad is the security of patient information and loss or theft of the device, McEntee said.
"To comply with HIPAA, the iPad would have to be locked with a pass key and the access to imaging should be via a Web server," McEntee said. "This should be password-authenticated and encrypted."
Also, no images should be stored on the device itself, he said.
"The locked-down nature of the hardware for the iPad means that it is very difficult to operate as a replacement for a laptop," McEntee said. "You cannot save files to the iPad; although certain apps allow a similar functionality, this seeming disadvantage makes it more secure from an imaging perspective. If lost, you can be assured that -- provided the previous user logged out -- there are no patient data on the iPad."
Hospital IT departments will have to work on the logistics of ensuring secure access to data, according to Honeyman-Buck. "These devices cannot be left lying around where another person could access protected patient information," she said.
The tablet PC's larger size can also be a detriment. Because it won't fit in a pocket, it will need some sort of shoulder-strap cover that doesn't impede the physician's easy access to the screen, Honeyman-Buck said.
In contrast to the more mobile form factor provided by the iPhone, the iPad would probably take the place of a patient chart -- kept in a slot on a bed or a wall, and picked up by various different users when access to enterprise data is needed, TeraRecon's Taylor said.
"So, the iPad will need some software changes to find a niche in healthcare, because it will need to be a locked-down, tightly controlled IT asset accessible safely by multiple users -- in that regard, it's not there yet," Taylor said.
The weight of the iPad can make it difficult to carry around and use, Foresight's Molinari said. In addition, it suffers from connectivity issues (such as no USB support).
And institutions need to be aware of more than just the physical security of the iPad. A virtual private network (VPN) will be required to use the iPad for secure, HIPAA-compliant remote viewing of images, CoActiv's Heere said.
"Perhaps future Apple [operating system] versions and future apps will allow the use of SSL connectivity like on our PC platforms, eliminating the need for VPN tunnels," Heere said.
FDA impact
Also yet to be determined is the impact on the iPad of the U.S. Food and Drug Administration's (FDA) decision earlier this year to classify MIMvista's Mobile MIM iPhone image viewing software as a class III device requiring premarket approval (PMA). If the FDA's decision stands, it could hamstring the development of commercial image review apps by requiring software developers to go through the time-consuming PMA process.
Indeed, MIMvista's Cain believes that the FDA's logic in regulating iPhone software would also apply to the iPad.
"The iPad makes portable image viewing significantly more usable and practical, which seems to challenge the claim that it is not a medical device," he said.
Merge's Merrild said that his company believes there will not be issues with the FDA regarding radiology workflow tasks such as scheduling, insurance verification, billing, and report viewing.
"Even with very limited image viewing capabilities -- without the presence of measurement tools or advanced features such as [multiplanar reformatting] or angle measurements -- this will likely be acceptable to regulators and users," Merrild said.
In the meantime, innovation in terms of mobile image review will definitely be limited until the FDA or other authorities in other jurisdictions provide a clear ruling on the use of these devices as part of a diagnostic toolset, Merrild said.
"We have confidence that these regulatory issues will eventually be resolved," Merrild said. "We believe the larger issue facing patient safety in radiology currently is the use of open-source [non-FDA approved] software on workstations."
CoActiv's Heere believes the initial and somewhat undefined position of the FDA on the use of mobile devices in radiology will ultimately be resolved in favor of a "patient care" approach.
"A strict interpretation of some of the current information would suggest that even the use of laptop or notebook computers would require a PMA for use in radiology," Heere said. "This would create a real problem for the hundreds of thousands of current users of these existing mobile devices. Until a formal published position is released by the FDA, we stand by our original position that the iPhone and iPad use of any of our products is strictly for review purposes and not for any diagnostic or interpretive use."
By Erik L. Ridley
AuntMinnie.com staff writer
June 24, 2010
Scientists Create 3D Models of Whole Mouse Organs
Yale University engineers have for the first time created 3D models of whole intact mouse organs, a feat they accomplished using fluorescence microscopy. The team reports its findings in the May/June issue of the Journal of Biomedical Optics, in a study published online this week.
Combining an imaging technique called multiphoton microscopy with “optical clearing,” which uses a solution that renders tissue transparent, the researchers were able to scan mouse organs and create high-resolution images of the brain, small intestine, large intestine, kidney, lung and testicles. They then created 3D models of the complete organs—a feat that, until now, was only possible by slicing the organs into thin sections or destroying them in the process, a disadvantage if more information about the sample is needed after the fact.
With traditional microscopy, researchers are only able to image tissues up to depths on the order of 300 microns, or about three times the thickness of a human hair. In that process, tissue samples are cut into thin slices, stained with dyes to highlight different structures and cell types, individually imaged, then stacked back together to create 3D models. The Yale team, by contrast, was able to avoid slicing or staining the organs by relying on natural fluorescence generated from the tissue itself.
When combined with optical clearing, multiphoton microscopy—so called because it uses photons to excite naturally fluorescent cells within the tissue—can image a larger field-of-view at much greater depths and is limited only by the size of the lens used. Once the tissue is cleared using a standard solution that makes it virtually transparent to optical light, the researchers shine different wavelengths of light on it to excite the inherently fluorescent tissue. The fluorescence is displayed as different colors that highlight the different structures and tissue types (in the lung, for example, collagen is depicted as green while elastin shows up as red).
“The intrinsic fluorescence is just as effective as conventional staining techniques,” said Michael Levene, associate professor at the Yale School of Engineering & Applied Science and the team leader. “It’s like creating a virtual 3D biopsy that can be manipulated at will. And you have the added benefit that the tissue remains intact even after it’s been imaged.”
The Yale team was able to reach depths in excess of two millimeters—deep enough to image complete mouse organs. Typical tissue samples taken during patient biopsies are about this size as well, meaning the new technique could be used to create 3D models of biopsies, Levene said. This could be especially useful in tissues where the direction of a cancerous growth may make it difficult to know how to slice tissue sample, he noted.
In addition, the technology could eventually be used to trace fluorescent proteins in the mouse brain and see where different genes are expressed, or to trace where drugs travel in the body using fluorescent tagging, for example.
“Fluorescence microscopy plays such a key role throughout biology and medicine,” Leven said. “The range of applications of this technique is immense, including everything from improved evaluation of patient tissue biopsies to fundamental studies of how the brain is wired.”
Other authors of the paper include Sonia Parra, Thomas Chia and Joseph Zinter, all of Yale University.
Citation: Journal of Biomedical Optics 15(3), 036017 (May/June 2010)
The Art of the Potentially Deadly Deal: Marketing Heroin on the Street
The empty glassine packets can be found in Manhattan, Brooklyn and beyond, scattered on streets and sidewalks with only obscure slogans or graphic images to suggest their former use. At one time they contained heroin and the markings stamped on the packets were meant to differentiate strains of varying purity or provenance.
To some they are crime evidence. Addicts may see them mainly as a vehicle to fulfill a dangerous urge. For a group of artists who have been collecting them they are cultural artifacts that are equally unsettling and compelling.
On Wednesday a weeklong show called “Heroin Stamp Project” organized by seven members of the Social Art Collective is scheduled to open at the White Box Gallery on Broome Street on the Lower East Side. The show, which will include 150 packets picked off city streets, as well as 12 blown-up prints made from them, is meant to examine the intersection of advertising and addiction and provoke questions about how society addresses dependence and disease.
Amazing Auction Alert #2: "The Owsten Collection," June 25th and 26th, Sydney, Australia
Exercise in Adolescence May Cut Risk of Deadly Brain
(HealthDay News) -- Exercising during adolescence may help guard against a deadly form of brain tumor in adulthood, new research suggests.
The study also found that avoiding obesity during the teen years was associated with a lower risk of developing the cancerous brain tumors called gliomas, while being tall increased the chances of such malignancies.
The study appears in the Nov. 1 issue of Cancer Research.
Gliomas are the most common type of brain and central nervous system cancers, accounting for 80 percent of cases, according to background information in the study. Gliomas cause 13,000 deaths in the United States each year.
Though little is known about why people develop the tumors or who is at risk, previous research has hinted that "early life exposures" may increase the risk of developing the cancer in adulthood, said study author Steven C. Moore, a research fellow in the Nutritional Epidemiology Branch of the U.S. National Cancer Institute. Studies have shown that people who are left-handed, for example, are at higher risk of the disease. Read more...
Precision breast panel analysis with the Ventana VIAS Image System
Ventana
Medical Systems, Inc., the leading provider of automated image analysis tools
for breast panel interpretation, recently announced that the CAP HQIP-B 2009
Survey for laboratory proficiency testing of HER2/neu showed the Ventana VIAS
image analysis system as the first choice of labs around the country. In the
recent CAP survey the VIAS was used for automated image analysis of HER2/neu by
46% of laboratory sites using automated analysis.
As
pathologists become more involved in generating information that directly
impacts treatment decisions as part of the personalized medicine model, there
is an increasing need for advanced laboratory tools that go beyond traditional
methods and diagnostics. The VIAS system is an automated system that can assist
the pathologist in the assessment of breast cancer protein markers such as HER-
2/neu, ER, PR, p-53, and Ki67. After the primary diagnosis is made, the
pathologist can choose to utilize the VIAS system to quantify the level of
estrogen receptor, progesterone receptor or HER2 protein objectively via
computerized algorithms rather than relying solely on subjective assessment,
which can vary between observers of different skill levels.
Ventana
Medical Systems is committed to providing innovative solutions for digital
pathology and image analysis as part of their product offering for hospitals
and laboratories throughout the country. The Sierra Medical Center in El Paso,
Texas started utilizing the image analysis system in 2008, and has seen its
tremendous value for the past couple of years in allowing pathologists to
detect and classify cancerous cells more quickly. “The VIAS image analysis
system improves the accuracy of immunohistochemistry testing and provides
reproducible results when interrupting breast cancer cases,” says pathologist
Dr. Judith Pester, Pathologist at Sierra Medical Center. “VIAS has been
instrumental in providing us with more accurate test results and ensuring that
patients receive appropriate treatment of their breast carcinoma.”
About
CAP Proficiency Testing
The
College of American Pathologists (CAP) Surveys program is the largest external
quality assessment program in the world. As such, it provides an unparalleled
selection of challenges and offers the largest database in existence for
interlaboratory comparison. The CAP has accumulated significant experience in
managing this type of program and is knowledgeable in its uses and limitations.
http://www.cap.org
About
Ventana Medical Systems, Inc.
Ventana
develops, manufactures, and markets instrument/reagent systems that automate
tissue preparation and slide staining in clinical histology and drug discovery
laboratories worldwide. The Company's clinical systems are important tools used
in the diagnosis and treatment of cancer and infectious diseases. Ventana drug
discovery systems are used to accelerate the discovery of new drug targets and
evaluate the safety of new drug compounds. In addition, the Company offers
premier workflow solutions designed to improve laboratory efficiency, providing
safeguards to enhance the quality of healthcare. Ventana is a wholly owned
member of the Roche Group. For more information on Ventana Medical Systems,
Inc. visit http://www.ventanamed.com.
Contact: Alana Bolton, Phone:
520.229.4164 / e-mail: alana.bolton@ventana.roche.com
Various works by Karol Bak
Karol Bak is a polish artist currently working out of Poznan, Poland. He studied at the Academy of Fine Arts in Poznan and graduated in 1989. His figurative works are inspired by myth and mythology. You can view more of Karol’s work by visiting the links below.
To view more please visit the following links:
Dako and Omnyx Sign Agreement within Digital Pathology
GLOSTRUP, Denmark & PITTSBURGH, Jun 21, 2010 (BUSINESS WIRE) -- Dako, a Danish-based world leader in tissue-based cancer diagnostics, and Omnyx, a leader in digital pathology solutions, announced today that they have entered into a three-year agreement to develop clinical algorithms for digital pathology. The aim is to support pathologists in generating even more accurate, objective and reproducible diagnostic results.
Under the agreement, Dako will utilize its expertise in staining and image analysis to develop image analysis algorithms that will be incorporated into the Omnyx digital pathology platform as part of Omnyx's overall strategy of providing pathologists with a comprehensive digital work environment. The algorithms developed under the agreement will be specifically optimized for Dako's breast cancer panel of immunohistochemical and in-situ hybridization tests.
"Digital pathology offers significant potential to improve the quality of cancer diagnosis by improving the consistency of test interpretation. The Omnyx/Dako partnership will help standardize the reagent-to-result process and enhance the ability of pathologists to interpret breast cancer tests," says Mike Becich, vice chair of Pathology Informatics at the University of Pittsburgh Medical Center in Pittsburgh.
Immunohistochemical and in-situ hybridization tests are widely used by pathologists worldwide to help determine the diagnosis and prognosis and predict patients' response to specific therapies for a large number of cancers, including breast cancer. Digital pathology is enabled by imaging systems and computer technology that allow for the digitization of glass slides and efficient management of the resulting image data. It enables pathologists to improve productivity by reviewing tissue sections without handling traditional glass slides and to interpret tissue-based test results more objectively with the help of image analysis algorithms. Digital pathology also holds tremendous potential for standardizing test interpretation and for improving accuracy in cancer diagnostics.
"Dako is committed to improving patient care by finding ways to further enhance the standards and accuracy in cancer diagnostics," said Lars Holmkvist, CEO of Dako. "This agreement with Omnyx is another important step in the implementation of our strategy by joining forces with strong digital pathology partners. Digital pathology is important as it offers great potential to improve the quality of cancer diagnosis and care by helping standardize test interpretation to the benefit of pathologists and their patients."
"Omnyx sees a future where algorithms help pathologists make better clinical decisions," said Gene Cartwright, CEO of Omnyx. "Our partnership with Dako will allow us to provide reliable, high-performance IHC algorithms to clinicians who use Dako tests. Enabling algorithms within the context of a complete digital workflow environment provides pathologists with a powerful set of tools to improve both confidence and efficiency."
About Immunohistochemistry
Immunohistochemistry refers to the process of localizing antigens (e.g. proteins) in cells of a tissue section exploiting the principle of antibodies binding specifically to antigens in biological tissues. Immunohistochemical staining is widely used in the diagnosis of abnormal cells such as those found in cancerous tumors.
About Dako
Dako, based in Denmark, is a global leader in tissue-based cancer diagnostics. Hospital and research laboratories worldwide use Dako's know-how, reagents, instruments and software to make precise diagnoses and determine the most effective treatment for patients suffering from cancer. Employing more than 1000 persons and operating in more than 70 countries, Dako covers essentially all of the global anatomic pathology markets.
About Omnyx
Omnyx, LLC is a joint venture of GE Healthcare and The University of Pittsburgh Medical Center with locations in Pittsburgh and Piscataway, NJ. The company is developing an enterprise platform to transform the scope of pathology to an all-digital workflow. The company will sell their digital pathology platform to clinical labs and offer an enterprise software platform for image management, workflow automation, image analysis algorithms and system integration along with its high speed whole-slide scanners. Close collaboration with pathologists at UPMC and other institutions along with their relationship with GE Healthcare allows Omnyx to focus its innovation on the needs of anatomic pathologists worldwide. Omnyx digital pathology products are currently in development and have not yet been cleared by the FDA.
SOURCE: Omnyx, LLC
"Woman Advertising J.M. Dolph, Furniture Maker and Undertaker," Cabinet card, circa 1877
Woman Advertising J.M. Dolph, Furniture Maker and Undertaker
W. Peppets Art Gallery, Homer, Michigan
Cabinet card, circa 1877A peculiar advertising photographic pictorial was devised during the 1870s. Women were posed holding signs heralding businesses, their dresses and bodies decorated with life-size objects related to the business. This woman’s hat is adorned with rings from coffin robes. On her chest, she sports a coffin plate, and above and beneath that plate are handles from a coffin. Around her neck is another coffin plate, and coffin chains and paraphernalia hang from her dress. Furniture makers became coffin makers as a natural extension of woodworking skills. The large frame [on the skirt of her dress] indicates this establishment also made frames.
From the wonderful Sleeping Beauty II - Grief, Bereavement and the Family in Memorial Photography by Stanley B. Burns, M.D.
As posted on Liquid Night and picked up by Turn of the Century.
Like Humans, Chimps Ape Their Betters
(HealthDay News) -- Just as humans tend to model their behavior after that of famous and admired individuals, chimpanzees also appear to copy the example of their older, higher-status cohorts, new research reveals.
The finding that chimpanzees share the human inclination to adopt new behaviors and problem-solve based on the influence of what anthropologists call "prestige" is new, and is the result of a collaborative investigation conducted by researchers at Emory University in Atlanta, the University of St. Andrews in Scotland, and Beloit College, Wisc.
The authors published their findings in the May 20 issue of PLoS One.
Celebrities, politicians and community leaders are the figures of emulation for people. Previously, the practice of mimicking behavior in this way was thought to be uniquely human. Read more...
















